A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)

BACKGROUND: Stereotactic ablative body radiotherapy (SABR) is emerging as a non-invasive method for precision irradiation of lung tumours. However, the ideal dose/fractionation schedule is not yet known. The primary purpose of this study is to assess safety and efficacy profile of single and multi-f...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Autores principales: Siva, Shankar, Kron, Tomas, Bressel, Mathias, Haas, Marion, Mai, Tao, Vinod, Shalini, Sasso, Giuseppe, Wong, Wenchang, Le, Hien, Eade, Thomas, Hardcastle, Nicholas, Chesson, Brent, Pham, Daniel, Høyer, Morten, Montgomery, Rebecca, Ball, David
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4778366/
https://ncbi.nlm.nih.gov/pubmed/26944262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2227-z
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares